T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $883B
1-Year Return 25.8%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Return
-2.6%
1 Year Return
+25.8%
3 Year Return
+128.18%
5 Year Return
+198.37%
10 Year Return
+601.91%
AUM
$610B
AUM Growth
-$181B
Cap. Flow
-$171B
Cap. Flow %
-28.04%
Top 10 Hldgs %
30.64%
Holding
3,111
New
151
Increased
1,366
Reduced
1,249
Closed
164

Sector Composition

1 Technology 26.11%
2 Healthcare 18.73%
3 Consumer Discretionary 14.62%
4 Financials 10.33%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SB icon
2876
Safe Bulkers
SB
$455M
$31K ﹤0.01%
+12,226
New +$31K
RUBY
2877
DELISTED
Rubius Therapeutics, Inc
RUBY
$31K ﹤0.01%
70,400
AGTC
2878
DELISTED
Applied Genetic Technologies Corporation
AGTC
$30K ﹤0.01%
108,680
-153,375
-59% -$42.3K
UP icon
2879
Wheels Up
UP
$1.4B
$29K ﹤0.01%
2,495
+976
+64% +$11.3K
ATOS icon
2880
Atossa Therapeutics
ATOS
$102M
$29K ﹤0.01%
34,400
ADV icon
2881
Advantage Solutions
ADV
$580M
$28K ﹤0.01%
13,026
-7,878,739
-100% -$16.9M
CTXR icon
2882
Citius Pharmaceuticals
CTXR
$20.9M
$28K ﹤0.01%
896
NAGE
2883
Niagen Bioscience, Inc. Common Stock
NAGE
$750M
$28K ﹤0.01%
22,500
CMRX
2884
DELISTED
Chimerix, Inc.
CMRX
$28K ﹤0.01%
+14,279
New +$28K
BKKT icon
2885
Bakkt Holdings
BKKT
$122M
$27K ﹤0.01%
+449
New +$27K
CLSD icon
2886
Clearside Biomedical
CLSD
$27.2M
$27K ﹤0.01%
23,200
LIDR icon
2887
AEye
LIDR
$112M
$27K ﹤0.01%
797
IMDX
2888
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$71M
$27K ﹤0.01%
1,830
HLGN
2889
DELISTED
Heliogen, Inc.
HLGN
$27K ﹤0.01%
+401
New +$27K
FATH
2890
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$27K ﹤0.01%
651
HYZN
2891
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$26K ﹤0.01%
+299
New +$26K
VIEW
2892
DELISTED
View, Inc. Class A Common Stock
VIEW
$26K ﹤0.01%
+319
New +$26K
GRNA
2893
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$26K ﹤0.01%
+10,976
New +$26K
SKIL icon
2894
Skillsoft
SKIL
$132M
$25K ﹤0.01%
+679
New +$25K
CELU icon
2895
Celularity
CELU
$64.3M
$24K ﹤0.01%
+1,024
New +$24K
APPH
2896
DELISTED
AppHarvest, Inc. Common Stock
APPH
$24K ﹤0.01%
+12,171
New +$24K
OUST icon
2897
Ouster
OUST
$1.59B
$23K ﹤0.01%
2,361
+1,118
+90% +$10.9K
SPIR icon
2898
Spire Global
SPIR
$276M
$23K ﹤0.01%
2,645
+1,153
+77% +$10K
PEAR
2899
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$22K ﹤0.01%
+10,400
New +$22K
OTLK icon
2900
Outlook Therapeutics
OTLK
$41.5M
$21K ﹤0.01%
830
+270
+48% +$6.83K